GlassScriptPhysician profile
Brian D Poliquin
NPI 1881836286
$6,003.62
in general payments reported to CMS, 2019-2025
34 companies · $1,320 in 2025
The $1,320 reported for 2025 was more than what 87% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,823 · 2022: $936 · 2023: $733 · 2024: $1,191 · 2025: $1,320.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,244.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,244.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,510.26 | 2021-2025 | |
| Amgen INC. | $938.55 | 2021-2025 | Repatha, Otezla, Evenity |
| Novo Nordisk INC | $753.69 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals LP | $696.95 | 2021-2025 | Breztri, Airsupra, Fasenra |
| Lilly USA, LLC | $438.93 | 2022-2025 | Jardiance, Mounjaro, Zepbound |
| Glaxosmithkline, LLC. | $250.52 | 2021-2025 | Shingrix, Arexvy, Trelegy Ellipta |
| Biohaven Pharmaceuticals, INC. | $228.27 | 2021 | |
| Esperion Therapeutics, INC. | $162.94 | 2021-2024 | Nexletol |
| Exact Sciences Corporation | $131.71 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Bayer Healthcare Pharmaceuticals INC. | $115.57 | 2024-2025 | |
| Avanir Pharmaceuticals, INC. | $115.00 | 2021 | |
| Pfizer INC. | $96.15 | 2024-2025 | |
| Dexcom, INC. | $77.93 | 2024-2025 | Dexcom G6 Transmitter |
| Abbott Laboratories | $63.24 | 2024-2025 | Freestyle Libre 3 |
| Kyowa Kirin, INC. | $39.96 | 2025 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Radius Health, INC. | $38.62 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $37.71 | 2022 | |
| Insulet Corporation | $36.58 | 2025 | Omnipod |
| Boehringer Ingelheim Pharmaceuticals, INC. | $29.86 | 2022-2025 | Ofev |
| Mannkind Corporation | $27.00 | 2024 | |
| Philips North America LLC | $24.78 | 2024 | (Ck7) Extended Holter |
| Halozyme INC | $20.09 | 2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $19.07 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $16.78 | 2025 | Xifaxan |
| Tolmar, INC. | $16.65 | 2025 | Jatenzo |
| Currax Pharmaceuticals LLC | $15.35 | 2025 | Contrave |
| Antares Pharma, INC. | $15.34 | 2023 | Nocdurna, Xyosted, Tlando |
| Novartis Pharmaceuticals Corporation | $15.27 | 2021 | |
| Arbor Pharmaceuticals, INC. | $14.48 | 2021 | |
| Horizon Therapeutics Plc | $13.94 | 2021 | |
| Genentech USA, INC. | $13.76 | 2021 | |
| Eisai INC. | $12.10 | 2021 | |
| Sanofi-Aventis U.S. LLC | $11.07 | 2021 | |
| Clarus Therapeutics INC. | $5.50 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Poliquin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.